{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:54:39Z","timestamp":1776750879461,"version":"3.51.2"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":37,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jcf.2019.08.023","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T04:55:23Z","timestamp":1572756923000},"page":"S74-S81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S2","title":["Adrenal function in cystic fibrosis"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8658-7831","authenticated-orcid":false,"given":"Maria Socorro","family":"Rayas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3595-0666","authenticated-orcid":false,"given":"Kara S.","family":"Hughan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2736-183X","authenticated-orcid":false,"given":"Tanicia","family":"Daley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Zangen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcf.2019.08.023_bb0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jcf.2019.08.023_bb0010","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000262533","article-title":"Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function","volume":"17","author":"Locatelli","year":"2010","journal-title":"Endocr Dev"},{"issue":"10","key":"10.1016\/j.jcf.2019.08.023_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102201","article-title":"Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis","volume":"18","author":"Paragliola","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.023_bb0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy, Asthma Clin Immunol"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.023_bb0025","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1542\/peds.2006-1612","article-title":"Adrenal insufficiency: still a cause of morbidity and death in childhood","volume":"119","author":"Shulman","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2019.08.023_bb0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000443915","article-title":"Secondary adrenal insufficiency: where is it hidden and what does it look like?","volume":"46","author":"Guaraldi","year":"2016","journal-title":"Front Horm Res"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.023_bb0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamapediatrics.2015.3526","article-title":"Endocrine effects of inhaled corticosteroids in children","volume":"170","author":"Kapadia","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.023_bb0040","first-page":"331","article-title":"Effects of inhaled corticosteroids on growth, bone metabolism, and adrenal function","volume":"64","author":"Wolfgram","year":"2017","journal-title":"Adv Pediatr Infect Dis"},{"issue":"7","key":"10.1016\/j.jcf.2019.08.023_bb0045","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1164\/rccm.200302-200OC","article-title":"Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children","volume":"168","author":"Agertoft","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.jcf.2019.08.023_bb0050","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch Intern Med"},{"issue":"7345","key":"10.1016\/j.jcf.2019.08.023_bb0055","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/bmj.324.7345.1081","article-title":"Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate","volume":"324","author":"Drake","year":"2002","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.jcf.2019.08.023_bb0060","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/0006-2952(83)90474-4","article-title":"Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes","volume":"32","author":"Kontula","year":"1983","journal-title":"Biochem Pharmacol"},{"issue":"15","key":"10.1016\/j.jcf.2019.08.023_bb0065","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/archinte.1997.00440360053005","article-title":"Glucocorticoidlike activity of megestrol. A summary of Food and Drug Administration experience and a review of the literature","volume":"157","author":"Mann","year":"1997","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.023_bb0070","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00280-003-0697-6","article-title":"Acute effects of megestrol on the hypothalamic-pituitary-adrenal axis","volume":"52","author":"Raedler","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.023_bb0075","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2007.04.018","article-title":"Incidence and risk factors for corticosteroid-induced lipodystrophy: a prospective study","volume":"57","author":"Fardet","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.023_bb0080","doi-asserted-by":"crossref","first-page":"404","DOI":"10.7861\/clinmedicine.11-4-404","article-title":"Cushing's syndrome with low levels of serum cortisol: the role of inhaled steroids","volume":"11","author":"Matos","year":"2011","journal-title":"Clin Med (Lond)"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.023_bb0085","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.amjmed.2013.11.024","article-title":"Adrenal suppression with cushingoid features from inhaled corticosteroid therapy in an adult asthmatic patient","volume":"127","author":"Tsoukas","year":"2014","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.023_bb0090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0277-5379(90)90231-H","article-title":"A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer","volume":"26","author":"Willemse","year":"1990","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.023_bb0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1086\/517681","article-title":"Cushing's syndrome induced by megestrol acetate in a patient with AIDS","volume":"27","author":"Padmanabhan","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.023_bb0100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1569-1993(03)00022-5","article-title":"Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450","volume":"2","author":"De Wachter","year":"2003","journal-title":"J Cyst Fibros"},{"issue":"9","key":"10.1016\/j.jcf.2019.08.023_bb0105","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1651-2227.2002.tb02894.x","article-title":"Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient","volume":"91","author":"Main","year":"2002","journal-title":"Acta Paediatr"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.023_bb0110","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1530\/EJE-15-0608","article-title":"Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol","volume":"173","author":"Woods","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.023_bb0115","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/adc.87.6.457","article-title":"Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom","volume":"87","author":"Todd","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2019.08.023_bb0120","first-page":"3629031","article-title":"Adrenal insufficiency in cystic fibrosis: a rare phenomenon?","volume":"2018","author":"Preville-Ratelle","year":"2018","journal-title":"Can Respir J"},{"issue":"8","key":"10.1016\/j.jcf.2019.08.023_bb0125","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/thorax.57.8.749","article-title":"Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis","volume":"57","author":"Parmar","year":"2002","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.023_bb0130","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.jcf.2014.09.007","article-title":"An unusual cause of growth failure in cystic fibrosis: a salutary reminder of the interaction between glucocorticoids and cytochrome P450 inhibiting medication","volume":"14","author":"Albert","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.023_bb0135","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jcf.2012.10.007","article-title":"Itraconazole and inhaled fluticasone causing hypothalamic-pituitary-adrenal axis suppression in adults with cystic fibrosis","volume":"12","author":"Gilchrist","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.023_bb0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1183\/09031936.02.00248002","article-title":"Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide","volume":"20","author":"Skov","year":"2002","journal-title":"Eur Respir J"},{"issue":"7\u20138","key":"10.1016\/j.jcf.2019.08.023_bb0145","article-title":"Rapid onset of iatrogenic adrenal insufficiency in a patient with cystic fibrosis-related liver disease treated with inhaled corticosteroids and a moderate CYP3A4 inhibitor","volume":"45","author":"Hoover","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jcf.2019.08.023_bb0150","first-page":"913574","article-title":"Adrenal crisis caused by inhaled fluticasone in an adolescent with cystic fibrosis and advanced hepatopathy: a case report","volume":"2012","author":"Denne","year":"2012","journal-title":"Case Rep Pulmonol"},{"issue":"11","key":"10.1016\/j.jcf.2019.08.023_bb0155","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-122-11-199506010-00017","article-title":"Megestrol for AIDS-related anorexia","volume":"122","author":"Maurer","year":"1995","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.023_bb0160","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF03344086","article-title":"High prevalence of adrenal suppression during acute illness in hospitalized patients receiving megestrol acetate","volume":"29","author":"Chidakel","year":"2006","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.jcf.2019.08.023_bb0165","first-page":"147265","article-title":"Megace mystery: a case of central adrenal insufficiency","volume":"2015","author":"Mehta","year":"2015","journal-title":"Case Rep Endocrinol"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.023_bb0170","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00043426-200305000-00013","article-title":"Mechanism of transient adrenal insufficiency with megestrol acetate treatment of cachexia in children with cancer","volume":"25","author":"Meacham","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.023_bb0175","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/cncr.11502","article-title":"Megestrol acetate in pediatric oncology patients may lead to severe, symptomatic adrenal suppression","volume":"98","author":"Orme","year":"2003","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.023_bb0180","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0022-3476(99)70467-1","article-title":"Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate","volume":"134","author":"Stockheim","year":"1999","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.jcf.2019.08.023_bb0185","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/PEC.0b013e31826288d2","article-title":"Decompensated septic shock in the setting of megace-induced severe adrenal suppression in an otherwise healthy pediatric patient: a case report","volume":"28","author":"Li","year":"2012","journal-title":"Pediatr Emerg Care"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.023_bb0190","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ppul.10184","article-title":"Adrenal insufficiency and testicular failure secondary to megestrol acetate therapy in a patient with cystic fibrosis","volume":"34","author":"McKone","year":"2002","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.023_bb0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/107327481602300212","article-title":"Pharmacy report: Megestrol acetate-induced adrenal insufficiency","volume":"23","author":"Nanjappa","year":"2016","journal-title":"Cancer Control"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.023_bb0200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.amjopharm.2008.08.004","article-title":"Megestrol acetate-associated adrenal insufficiency","volume":"6","author":"Bulchandani","year":"2008","journal-title":"Am J Geriatr Pharmacother"},{"issue":"10","key":"10.1016\/j.jcf.2019.08.023_bb0205","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.023_bb0210","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0022-3476(99)70058-2","article-title":"Risk factors for low bone mineral density in children and young adults with Crohn's disease","volume":"135","author":"Semeao","year":"1999","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.023_bb0215","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1542\/peds.91.6.1127","article-title":"Estimation of central osteopenia in children with chronic polyarthritis treated with glucocorticoids","volume":"91","author":"Kotaniemi","year":"1993","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.023_bb0220","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/gut.42.2.188","article-title":"Bone mineral density and nutritional status in children with chronic inflammatory bowel disease","volume":"42","author":"Boot","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.jcf.2019.08.023_bb0225","first-page":"38","article-title":"Effects of rheumatic disease and corticosteroid treatment on calcium metabolism and bone density in children assessed one year after diagnosis, using stable isotopes and dual energy x-ray absorptiometry","volume":"58","author":"Perez","year":"2000","journal-title":"J Rheumatol Suppl"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.023_bb0230","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1359\/jbmr.2003.18.5.913","article-title":"Children and the risk of fractures caused by oral corticosteroids","volume":"18","author":"van Staa","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.023_bb0235","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/thx.2005.046516","article-title":"Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis","volume":"61","author":"Buntain","year":"2006","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.jcf.2019.08.023_bb0240","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/thorax.57.8.719","article-title":"A prospective study of change in bone mineral density over one year in adults with cystic fibrosis","volume":"57","author":"Haworth","year":"2002","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.023_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-009-9316-9","article-title":"The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis","volume":"86","author":"Paccou","year":"2010","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.023_bb0250","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/MCP.0b013e3283659e35","article-title":"Cystic fibrosis-related bone disease","volume":"19","author":"Paccou","year":"2013","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.023_bb0255","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/0091270002239829","article-title":"Effect of inhaled steroids on bone mineral density: a meta-analysis","volume":"43","author":"Sharma","year":"2003","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.023_bb0260","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/(SICI)1099-0496(200003)29:3<188::AID-PPUL6>3.0.CO;2-K","article-title":"Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma","volume":"29","author":"Allen","year":"2000","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.023_bb0265","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1440-1754.2001.00628.x","article-title":"Bone mineral density in prepubertal asthmatics receiving corticosteroid treatment","volume":"37","author":"Harris","year":"2001","journal-title":"J Paediatr Child Health"},{"issue":"12","key":"10.1016\/j.jcf.2019.08.023_bb0270","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJM200003233421204","article-title":"Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis","volume":"342","author":"Lai","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.023_bb0275","doi-asserted-by":"crossref","DOI":"10.1542\/peds.106.1.e8","article-title":"The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis","volume":"106","author":"Sharek","year":"2000","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.023_bb0280","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.rmed.2006.04.009","article-title":"A comparison of the relative growth velocities with budesonide and fluticasone propionate in children with asthma","volume":"101","author":"Ferguson","year":"2007","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.jcf.2019.08.023_bb0285","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1001\/archpedi.155.11.1248","article-title":"Effects of 2 inhaled corticosteroids on growth: results of a randomized controlled trial","volume":"155","author":"de Benedictis","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.023_bb0290","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ppul.20598","article-title":"Growth deceleration of children on inhaled corticosteroids is compensated for after the first 12 months of treatment","volume":"42","author":"Anthracopoulos","year":"2007","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"10.1016\/j.jcf.2019.08.023_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133428","article-title":"Impact of inhaled corticosteroids on growth in children with Asthma: systematic review and meta-analysis","volume":"10","author":"Loke","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.023_bb0300","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/ebch.1989","article-title":"Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth","volume":"9","author":"Pruteanu","year":"2014","journal-title":"Evid Based Child Health"},{"issue":"10","key":"10.1016\/j.jcf.2019.08.023_bb0305","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1203229","article-title":"Effect of inhaled glucocorticoids in childhood on adult height","volume":"367","author":"Kelly","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.023_bb0310","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00431-006-0198-9","article-title":"Do inhaled corticosteroids impair long-term growth in prepubertal cystic fibrosis patients?","volume":"166","author":"De Boeck","year":"2007","journal-title":"Eur J Pediatr"},{"issue":"10","key":"10.1016\/j.jcf.2019.08.023_bb0315","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1464-5491.2007.02252.x","article-title":"Characteristics of adults with and without cystic fibrosis-related diabetes","volume":"24","author":"Adler","year":"2007","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.023_bb0320","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.amjmed.2008.09.048","article-title":"The association of inhaled corticosteroid use with serum glucose concentration in a large cohort","volume":"122","author":"Slatore","year":"2009","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.jcf.2019.08.023_bb0325","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/thx.48.10.974","article-title":"Effect of eight months of inhaled beclomethasone dipropionate and budesonide on carbohydrate metabolism in adults with asthma","volume":"48","author":"Kiviranta","year":"1993","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.jcf.2019.08.023_bb0330","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/thx.42.11.881","article-title":"Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects","volume":"42","author":"Kruszynska","year":"1987","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.023_bb0335","doi-asserted-by":"crossref","first-page":"183","DOI":"10.23736\/S0391-1977.17.02701-8","article-title":"Secondary adrenal insufficiency: from the physiopathology to the possible role of modified-release hydrocortisone treatment","volume":"43","author":"Paragliola","year":"2018","journal-title":"Minerva Endocrinol"},{"issue":"11","key":"10.1016\/j.jcf.2019.08.023_bb0340","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1210\/jc.2008-0710","article-title":"Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis","volume":"93","author":"Kazlauskaite","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.023_bb0345","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/eje.0.1500687","article-title":"Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients","volume":"150","author":"Kannisto","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.jcf.2019.08.023_bb0350","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1210\/jcem.86.10.7975","article-title":"Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression in asthmatic children treated with inhaled steroids","volume":"86","author":"Kannisto","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.023_bb0355","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jcem-67-2-400","article-title":"Effect of daily and alternate day low dose prednisone on serum cortisol and adrenal androgens in hirsute women","volume":"67","author":"Rittmaster","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcf.2019.08.023_bb0360","article-title":"Appetite stimulants for people with cystic fibrosis","volume":"7","author":"Chinuck","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.023_bb0365","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/02770903.2016.1196370","article-title":"Inhaled corticosteroid related adrenal suppression detected by poor growth and reversed with ciclesonide","volume":"54","author":"Liddell","year":"2017","journal-title":"J Asthma"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.023_bb0370","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S2213-2600(18)30058-4","article-title":"Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study","volume":"6","author":"Hawcutt","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"S2","key":"10.1016\/j.jcf.2019.08.023_bb0371","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jcf.2019.08.003","article-title":"Cystic fibrosis related diabetes: Medical management","volume":"18","author":"Ode","year":"2019","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199319308823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199319308823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:42:14Z","timestamp":1761601334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199319308823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":75,"alternative-id":["S1569199319308823"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2019.08.023","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adrenal function in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2019.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}